CAPR Archived Articles
Capricor Therapeutics (CAPR): A Pioneering Biotech Poised to Transform Duchenne Muscular Dystrophy Treatment
Published on November 17, 2024
Capricor Therapeutics, Inc. (NASDAQ:CAPR): A Transformative Cell Therapy Poised for Potential Approval in Duchenne Muscular Dystrophy
Published on September 24, 2024
